ASMZX | NRGSX | ASMZX / NRGSX | |
Total Expense Ratio | 0.96 | 0.74 | 130% |
Annual Report Gross Expense Ratio | 0.96 | 0.74 | 130% |
Fund Existence | 15 years | 13 years | - |
Gain YTD | -2.018 | -3.458 | 58% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 334M | 8.8B | 4% |
Annual Yield % from dividends | 0.00 | 0.06 | - |
Returns for 1 year | 3.29 | -7.18 | -46% |
Returns for 3 years | 27.22 | 9.33 | 292% |
Returns for 5 years | -23.91 | -1.44 | 1,656% |
Returns for 10 years | -11.68 | 10.14 | -115% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFMBX | 39.09 | 0.17 | +0.44% |
American Funds American Balanced F3 | |||
CECYX | 30.38 | N/A | N/A |
Columbia Large Cap Enhanced Core Inst3 | |||
GMCUX | 16.99 | N/A | N/A |
Goldman Sachs Small/Mid Cap Equity R6 | |||
PRIAX | 35.03 | N/A | N/A |
Principal Glb Emerging Markets A | |||
CVMAX | 22.22 | N/A | N/A |
Calvert Emerging Markets Equity A |